LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF WISKOTT-ALDRICH SYNDROME Read more about LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF WISKOTT-ALDRICH SYNDROME US Application 63/179,993Filed on 2021-04-26
STABILIZED SPIKE STEM-BASED PAN-BETACORONAVIRUS NANOPARTICLE VACCINES Read more about STABILIZED SPIKE STEM-BASED PAN-BETACORONAVIRUS NANOPARTICLE VACCINES US Application 63/583,090Filed on 2023-09-15
ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM5] Read more about ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM5] US Application 63/481,368Filed on 2023-01-24
ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM5] Read more about ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM5] US Application 63/381,842Filed on 2022-11-01
ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM5] Read more about ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM5] US Application 63/357,331Filed on 2022-06-30
ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM4] Read more about ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM4] US Application 63/381,850Filed on 2022-11-01
ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM4] Read more about ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM4] US Application 63/357,873Filed on 2022-07-01
ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM4] Read more about ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM4] US Application 63/357,336Filed on 2022-06-30
FORMULATION, STABILITY, PHARMACOKINETIC, AND MODELING STUDIES FOR TESTS OF SYNERGISTIC COMBINATIONS OF ORALLY AVAILABLE APPROVED DRUGS AGAINST EBOLA VIRUS IN VIVO Read more about FORMULATION, STABILITY, PHARMACOKINETIC, AND MODELING STUDIES FOR TESTS OF SYNERGISTIC COMBINATIONS OF ORALLY AVAILABLE APPROVED DRUGS AGAINST EBOLA VIRUS IN VIVO US Application 63/147,587Filed on 2021-02-09
Bispecific antibodies that broadly target coronaviruses Read more about Bispecific antibodies that broadly target coronaviruses US Application 63/528,158Filed on 2023-07-21